← SynDRA
ML-161
SynDRA canonical compound SYN0062935 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Mechanism of action | protease-activated receptor inhibitor |
|---|
Cross-references
Synonyms
- 2-bromo-N-(3-butyramidophenyl)benzamide
- RefChem:909683
- DTXCID10311013
- ML161
- 2-bromo-N-[3-(butanoylamino)phenyl]benzamide
- Parmodulin 2
- 2-Bromo-N-[3-[(1-oxobutyl)amino]phenyl]benzamide
- 2-BROMO-N-(3-BUTANAMIDOPHENYL)BENZAMIDE
- C17H17BrN2O2
- 2-bromo-N-[3-(butyrylamino)phenyl]benzamide
- MFCD03063772
- SMR000193713
- MLS000571703
- 2-BROMO-N-[3-[(1-OXOBUTYL)AMINO]PHENYL]-BENZAMIDE
- Cambridge id 5946339
- Oprea1_852187
- MLS002699906
- SCHEMBL882467
- orb1307220
- SCHEMBL29766853
- CHEBI:93032
- EX-A273
- DFOVLSMXPWPCFH-UHFFFAOYSA-N
- GLXC-02656
- HMS2461M06
- HMS3651N10
- YRA73593
- AG-670
- BDBM50386391
- EBC-07403
- s2916
- STL169237
- AKOS003193751
- CCG-268174
- ML 161?
- NCGC00371123-06
- NCGC00371123-09
- AC-35205
- AS-16666
Look up ML-161 in the interactive SynDRA portal →